3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Pancreatic carcinoma, familial
1
Pancreatic cancer, adult
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Neoplastic Cells, Circulating
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm, Residual
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Interventions
Paclitaxel
9
Carboplatin
8
Bevacizumab
8
fluzoparib
5
olaparib
3
Topotecan
3
Gemcitabine
3
liposomal doxorubicin
2
famitinib
2
apatinib
2
Oxaliplatin
2
Magnetic Resonance Spectroscopy
2
Indocyanine Green
2
Drug Therapy
2
Cisplatin
2
trametinib
1
senaparib
1
pembrolizumab
1
niraparib
1
montelukast
1
irinotecan sucrosofate
1
fludarabine
1
durvalumab
1
dalpiciclib
1
dabrafenib
1
ceralasertib
1
anlotinib
1
aldesleukin
1
Ultrasonography, Doppler
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Ovarian Neoplasms
×
Hematologic Tests
×
Clear all
NCT06329323
2024-03-26
SUMMER
Imperial College London
Not yet recruiting
24 enrolled